Journals / Türk Kardiyoloji Derneği Arşivi / 2016 / Cilt: 44 - Sayı: 6

Lotus kapak sistemi kullanılarak yapılan ve subklaviyan arter yoluyla uygulanan ilk transkateter aort kapak replasmanı

First trans-subclavian transcatheter aortic valve replacement using Lotus valve system

Pages
507–510
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The case of a 74-year-old man with severe AS and bilateral iliofemoral arteriopathy treated with left trans-subclavian (TS) TAVI using the Lotus valve system is described in the present report

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Transcatheter aortic valve implantation (TAVI), most commonly performed via retrograde femoral artery access, is a promising alternative to surgical aortic valve replacement in elderly, high-risk patients with severe aortic stenosis (AS).
📊
Key Findings & Data:Approximately one-third of these patients suffer from severe iliofemoral arteriopathy, ruling out transfemoral approach.
💡
Conclusion & Impact:The case of a 74-year-old man with severe AS and bilateral iliofemoral arteriopathy treated with left trans-subclavian (TS) TAVI using the Lotus valve system is described in the present report
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Transcatheter aortic valve implantation (TAVI), most commonly performed via retrograde femoral artery access, is a promising alternative to surgical aortic valve replacement in elderly, high-risk patients with severe aortic stenosis (AS). Approximately one-third of these patients suffer from severe iliofemoral arteriopathy, ruling out transfemoral approach. The case of a 74-year-old man with severe AS and bilateral iliofemoral arteriopathy treated with left trans-subclavian (TS) TAVI using the Lotus valve system is described in the present report

Özet

Transkateter aort kapak implantasyonu (TAVI) ciddi aort darlığı olan yüksek riskli yaşlı hastalarda cerrahi aort kapak replasmanına karşı umut verici bir tedavi seçeneğidir. Çoğunlukla geriye doğru, femoral arter yolu ile uygulanır. Ancak, bu hastaların yaklaşık üçte birinde ciddi iliyofemoral arter hastalığı da olduğundan femoral yolla işlemi yapmak her zaman mümkün olmayabilir. Bu yazıda, ciddi aort darlığı ve iki taraflı iliyofemoral arter hastalığı olan, bu nedenle sol subklaviyan arter yoluyla Lotus kapak sistemi kullanılarak TAVI uygulanan 74 yaşında bir erkek hasta sunuldu

🔖

Cite This Article

BAŞTUĞ, S., ASLAN, A. N., SÜYGÜN, H., SARI, C., BOZKURT, E. (2022). Lotus kapak sistemi kullanılarak yapılan ve subklaviyan arter yoluyla uygulanan ilk transkateter aort kapak replasmanı. Türk Kardiyoloji Derneği Arşivi, Cilt: 44 - Sayı: 6, 507–510. https://ajindex.com/articles/632456

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cun- ningham AD, Young CP, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8.
  2. Muensterer A, Mazzitelli D, Ruge H, Wagner A, Hettich I, Piazza N, et al. Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access. Clin Res Cardiol 2013;102:627-36.
  3. Bruschi G, Fratto P, De Marco F, Oreglia J, Colombo P, Botta L, et al. The trans-subclavian retrograde approach for trans- catheter aortic valve replacement: single-center experience. J Thorac Cardiovasc Surg 2010;140:911-5,
  4. Blumenstein J, Van Linden A, Kempfert J, Kim WK, Liebetrau C, Hamm C, et al. Retrograde, transsubclavian implantation of a SAPIEN XT(TM) aortic valve prosthesis with the Edwards NovaFlex+(TM) system. Clin Res Cardiol 2012;101:773-5.
  5. Witkowski A, Dabrowski M, Chmielak Z, Demkow M, Stepinska J, Juraszynski Z, et al. Transcatheter aortic valve implantation using transfemoral/transsubclavian or transapi- cal approach: 30-day follow-up of the initial 30 patients. Kar- diol Pol 2011;69:105-14.
  6. Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klug- mann S, Maisano F, et al. Safety and efficacy of the sub- clavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010;3:359-66.